KD7-33270-20488
4 vaccinations
1 coded response
6 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 070 / NJ
- Registered
- 2022-10-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-23
Dose 1 — Moderna
-
2021-05-21
Dose 2 — Moderna
-
2021-11-27
Dose 3 — Moderna
-
2022-10-01
Dose 4 — Moderna
-
2022-10-22
Registered in v-safe
- 2022-10-22
- 2022-10-29
- 2022-11-05
- 2022-11-12
-
2022-12-31
Survey response — 3 months, dose 4MedDRA: Immune system disorder, Nasopharyngitis, Pregnancy — Feeling: GoodFree text: Strong cold-like symptoms for a couple of weeks. It was likely a simple cold, just felt stronger and stayed longer because I'm pregnant (weaker immunity) and stayed away from usual cold medicine, like Cold-Eeze/Theraflu.MedDRA releases: 2024-11 · check-in free text available
- 2023-04-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-23 | Moderna | No |
| 2 | 2021-05-21 | Moderna | No |
| 3 | 2021-11-27 | Moderna | No |
| 4 | 2022-10-01 | Moderna | No |
Free text
Release 12 — 3 months, dose 4
Symptoms: Strong cold-like symptoms for a couple of weeks. It was likely a simple cold, just felt stronger and stayed longer because I'm pregnant (weaker immunity) and stayed away from usual cold medicine, like Cold-Eeze/Theraflu.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Immune system disorder | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release